Hiroshi Gomyo

Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

Ritsuro Suzuki, Motoko Yamaguchi, Koji Izutsu et al. · Blood · 2011 · 193 citations · Full text

Medicine, Immunology, Oncology +10

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study

Naoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura et al. · International Journal of Hematology · 2017 · 94 citations

Medicine, Hematology, Oncology +3

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

T Sugimoto, Hiranmoy Das, Shion Imoto et al. · American Journal of Hematology · 2000 · 47 citations · Full text

Medicine, Hematology, Oncology +17

Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707

Yoshinobu Maeda, Hisakazu Nishimori, Isao Yoshida et al. · Haematologica · 2017 · 42 citations · Full text

Medicine, Oncology, Chemotherapy +13

Primary Hepatic Follicular Lymphoma: A Case Report and Discussion of Chemotherapy and Favorable Outcomes

Hiroshi Gomyo, Yoshitoyo Kagami, Harumi Kato et al. · Journal of Clinical and Experimental Hematopathology · 2007 · 35 citations · Full text

Medicine, Hematology, Oncology +11